These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37307496)

  • 1. A novel pyrosequencing strategy for RHD zygosity for predicting risk of hemolytic disease of the fetus and newborn.
    Lv P; Li J; Yao Y; Fan X; Liu C; Li H; Zhou H
    Lab Med; 2024 Mar; 55(2):145-152. PubMed ID: 37307496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid
    Sillence KA; Halawani AJ; Tounsi WA; Clarke KA; Kiernan M; Madgett TE; Avent ND
    Clin Chem; 2017 Aug; 63(8):1388-1397. PubMed ID: 28615230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of RhD zygosity: comparison of a double amplification refractory mutation system approach and a multiplex real-time quantitative PCR approach.
    Chiu RW; Murphy MF; Fidler C; Zee BC; Wainscoat JS; Lo YM
    Clin Chem; 2001 Apr; 47(4):667-72. PubMed ID: 11274016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paternal RHD zygosity determination in Tunisians: evaluation of three molecular tests.
    Kacem N; Jemni-Yacoub S; Chiaroni J; Bailly P; Silvy M
    Blood Transfus; 2015 Jan; 13(1):59-65. PubMed ID: 24960665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cold case of hemolytic disease of the fetus and newborn resolved by genomic sequencing and population studies to define a new antigen in the Rh system.
    Wilson B; Davison CL; Lopez GH; Millard GM; Liew YW; Powley T; Campbell T; Jadhao SS; Nagaraj SH; Perry M; Roulis EV; Toombs M; Irving DO; Flower RL; Hyland CA
    Transfusion; 2024 Jun; 64(6):1171-1176. PubMed ID: 38686705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RHD zygosity assignments based on most probable genotype and hybrid Rhesus box detection in Tunisia.
    Kacem N; Chakroun T; Moussa H; Abdelkefi S; Houissa B; Chiaroni J; Jemni Yacoub S
    Transfus Med; 2012 Oct; 22(5):362-6. PubMed ID: 22757646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of RHD by real-time polymerase chain reaction for determination of RHD zygosity and RHD mosaicism/chimerism: an evaluation of four quantitative methods.
    Krog GR; Clausen FB; Dziegiel MH
    Transfusion; 2007 Apr; 47(4):715-22. PubMed ID: 17381631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Applications of RHD zygosity test through polymerase chain reaction for prediction of fetus Rh D-positive phenotype].
    Shao CP
    Zhonghua Fu Chan Ke Za Zhi; 2003 Apr; 38(4):223-5. PubMed ID: 12885370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing RHD zygosity in India: a step into the future of foetal and neonatal haemolytic disease prevention.
    Aggarwal S; Arya V; Agarwal S
    Transfus Med; 2011 Jun; 21(3):190-3. PubMed ID: 21198998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RHD and RHCE variant and zygosity genotyping via multiplex ligation-dependent probe amplification.
    Haer-Wigman L; Veldhuisen B; Jonkers R; Lodén M; Madgett TE; Avent ND; de Haas M; van der Schoot CE
    Transfusion; 2013 Jul; 53(7):1559-74. PubMed ID: 23043317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular determination of RHD zygosity: predicting risk of hemolytic disease of the fetus and newborn related to anti-D.
    Pirelli KJ; Pietz BC; Johnson ST; Pinder HL; Bellissimo DB
    Prenat Diagn; 2010 Dec; 30(12-13):1207-12. PubMed ID: 21072752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemolytic disease of the fetus and newborn in the molecular era.
    Fasano RM
    Semin Fetal Neonatal Med; 2016 Feb; 21(1):28-34. PubMed ID: 26589360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A new PCR method for direct determination of RHD zygosity].
    Shao CP; Xiong W
    Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):736-9. PubMed ID: 15200910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular background of weak D type 15 as the predominant weak D type found in Chinese population].
    Sun GD; Duan XM; Zhang YP; Yin ZZ; Niu XL; Li YF; Zhao YL; Niu HJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Oct; 14(5):1024-8. PubMed ID: 17096912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management Considerations for Air Medical Transport Programs Transfusing RhD-Positive Red Blood Cell-Containing Products to Females of Childbearing Potential.
    McCartin MP; Wool GD; Thomas SA; Panfil M; Schoenfeld D; Blumen IJ; Tataris KL; Thomas SH
    Air Med J; 2024; 43(4):348-356. PubMed ID: 38897700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RHD 1227 A and hybrid Rhesus box analysis in Thai RhD+ and RhD- blood donors: Prevalence, RHD zygosity, and molecular screening.
    Simtong P; Phothi R; Puapairoj C; Leelayuwat C; Romphruk AV
    Transfus Apher Sci; 2022 Dec; 61(6):103496. PubMed ID: 35810119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhesus-D zygosity and hemolytic disease of fetus and newborn.
    Moghaddam M; Naghi A; Hassani F; Amini S
    Asian J Transfus Sci; 2013 Jul; 7(2):156-7. PubMed ID: 24014950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal RHD gene determination and dosage analysis by PCR: clinical evaluation.
    Chan FY; Cowley NM; Wolter L; Stone M; Carmody F; Saul A; Hyland CA
    Prenat Diagn; 2001 Apr; 21(4):321-6. PubMed ID: 11288127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethical considerations in the use of RhD-positive blood products in trauma.
    Malone JR
    Transfusion; 2024 May; 64 Suppl 2():S4-S10. PubMed ID: 38491917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RHD Genotyping of Rh-Negative and Weak D Phenotype among Blood Donors in Southeast Iran.
    Sadeghi-Bojd Y; Amirizadeh N; Oodi A
    Int J Hematol Oncol Stem Cell Res; 2021 Oct; 15(4):213-220. PubMed ID: 35291662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.